PMA device
ARCHITECT AFP, Alinity i AFP
Abbott Laboratories · Kit, Test, Alpha-Fetoprotein For Neural Tube Defects (LOK, Class III) · First FDA decision Oct 11, 2023, newest Oct 11, 2023Genetic and newborn screening
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "ARCHITECT AFP Alinity"
MAUDE reports
0
Brand "ARCHITECT AFP Alinity", since 2015
PubMed studies
0
Mentioning "ARCHITECT AFP Alinity"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ARCHITECT AFP, Alinity i AFP
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ARCHITECT AFP, Alinity i AFPPMA supplement
P120008-S022 · Decided Oct 11, 2023 · 237 days after receipt · Normal 180 Day Track
Device type: KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS (LOK) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ARCHITECT AFP Alinity", any status and sponsor, newest update first.
No registered device study names "ARCHITECT AFP Alinity".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ARCHITECT AFP Alinity", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOK
140 reports: 140 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ARCHITECT AFP Alinity"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOK.
- Access AFP (on DxI 9000 Analyzer)Beckman Coulter, Inc. · PMA 2025
- Architect AfpAbbott Laboratories · PMA 2020
- Atellica IM Alpha Fetoprotein (AFP)Siemens Healthcare Diagnostics, Inc. · PMA 2024
- Axsym AfpAbbott Laboratories · PMA 2011
- Alinity i AFPAbbott Laboratories · PMA 2020
- Advia Centaur Afp AssaySiemens Healthcare Diagnostics, Inc. · PMA 2018
- Immulite/Immulite 1000/IMMULITE 2000/IMMULITE 2500 AfpSiemens Healthcare Diagnostics, Inc. · PMA 2010
- Immulite 2000 AfpSiemens Healthcare Diagnostics, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.